Dräger Companion med icon

1.1.3 by Drägerwerk


Apr 25, 2024

About Dräger Companion med

With self-control, security and motivation in alcohol abstinence.

The Dräger Companion med serves as personal support for abstinence from alcohol and therapy and was developed for those affected with diagnosed alcohol dependence (F10.2).

Dräger Companion med is a combination of app and alcohol tester that you can use to test yourself regularly and easily, anywhere. You can view your test results at any time. Celebrate your milestones with the abstinence counter. If you feel insecure, your therapy contacts are just a click away. Integrate Companion med into your therapy and get a direct connection to your specialist staff.

In order to take full advantage of the app, you need a breathalyser, the Dräger Companion 4me. For more information, visit www.draeger.com/companion-med.

The app includes the following features:

• Support for abstinence

• Create and customize test plans

• Independent submission of breath alcohol tests

• Direct feedback on test results

• Regular reminders about upcoming tests

• Test history can be viewed at any time

• User motivation

• View various milestones that have been reached

• Questioning the confidence in abstinence

What's New in the Latest Version 1.1.3

Last updated on Apr 25, 2024

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request Dräger Companion med Update 1.1.3

Requires Android

9

Available on

Get Dräger Companion med on Google Play

Show More

Dräger Companion med Screenshots

Comment Loading...
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.